| Product NDC: | 62592-496 |
| Proprietary Name: | Buphenyl |
| Non Proprietary Name: | sodium phenylbutyrate |
| Active Ingredient(s): | 500 mg/1 & nbsp; sodium phenylbutyrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 62592-496 |
| Labeler Name: | Ucyclyd Pharma Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020572 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19960513 |
| Package NDC: | 62592-496-03 |
| Package Description: | 1 BOTTLE in 1 CARTON (62592-496-03) > 250 TABLET in 1 BOTTLE |
| NDC Code | 62592-496-03 |
| Proprietary Name | Buphenyl |
| Package Description | 1 BOTTLE in 1 CARTON (62592-496-03) > 250 TABLET in 1 BOTTLE |
| Product NDC | 62592-496 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | sodium phenylbutyrate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19960513 |
| Marketing Category Name | NDA |
| Labeler Name | Ucyclyd Pharma Inc. |
| Substance Name | SODIUM PHENYLBUTYRATE |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC] |